Lars Steen

3.1k total citations
52 papers, 2.4k citations indexed

About

Lars Steen is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Lars Steen has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 13 papers in Surgery and 11 papers in Genetics. Recurrent topics in Lars Steen's work include Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Dermatological and Skeletal Disorders (9 papers) and Parathyroid Disorders and Treatments (7 papers). Lars Steen is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Dermatological and Skeletal Disorders (9 papers) and Parathyroid Disorders and Treatments (7 papers). Lars Steen collaborates with scholars based in Sweden, United Kingdom and Japan. Lars Steen's co-authors include Gösta Holmgren, Ole B. Suhr, Bo‐Göran Ericzon, Oluf Andersen, Philip N. Hawkins, Mark B. Pepys, Anna Danielsson, Andrew W. Seymour, Sylvia Richardson and B. Gunnar Wallin and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Diabetes Care.

In The Last Decade

Lars Steen

52 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Steen Sweden 23 1.8k 451 419 384 380 52 2.4k
Eliezer J. Holtzman Israel 25 1.2k 0.6× 305 0.7× 145 0.3× 316 0.8× 119 0.3× 69 2.1k
Zebulun D. Horowitz United States 11 826 0.5× 669 1.5× 173 0.4× 77 0.2× 188 0.5× 15 2.7k
Claude G. Biava United States 26 528 0.3× 190 0.4× 214 0.5× 85 0.2× 230 0.6× 46 1.9k
J V Leonard United Kingdom 24 598 0.3× 293 0.6× 276 0.7× 162 0.4× 121 0.3× 69 1.8k
P Lohse Germany 27 586 0.3× 450 1.0× 140 0.3× 81 0.2× 148 0.4× 57 1.4k
M Odièvre France 31 610 0.3× 2.0k 4.4× 315 0.8× 85 0.2× 616 1.6× 138 3.7k
Kirk N. Campbell United States 24 714 0.4× 219 0.5× 175 0.4× 248 0.6× 140 0.4× 68 2.5k
Minghui Zhao China 25 823 0.5× 124 0.3× 258 0.6× 86 0.2× 252 0.7× 96 2.0k
R.A. Hannon United Kingdom 26 931 0.5× 305 0.7× 195 0.5× 48 0.1× 108 0.3× 55 3.1k
George Hug United States 24 626 0.3× 198 0.4× 512 1.2× 95 0.2× 150 0.4× 76 1.9k

Countries citing papers authored by Lars Steen

Since Specialization
Citations

This map shows the geographic impact of Lars Steen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Steen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Steen more than expected).

Fields of papers citing papers by Lars Steen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Steen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Steen. The network helps show where Lars Steen may publish in the future.

Co-authorship network of co-authors of Lars Steen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Steen. A scholar is included among the top collaborators of Lars Steen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Steen. Lars Steen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adolfsson, Eva Thors, Janeth Leksell, Björn Eliasson, et al.. (2020). Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality: A nationwide register-based cohort study. Diabetes Research and Clinical Practice. 167. 108352–108352. 2 indexed citations
2.
Adolfsson, Eva Thors, Janeth Leksell, Björn Eliasson, et al.. (2018). Associations between quality of work features in primary health care and glycaemic control in people with Type 2 diabetes mellitus: A nationwide survey. Primary care diabetes. 13(2). 176–186. 4 indexed citations
3.
Rosenblad, Andreas, Janeth Leksell, Björn Eliasson, et al.. (2017). Resources and organisation in primary health care are associated with HbA1c level: A nationwide study of 230 958 people with Type 2 diabetes mellitus. Primary care diabetes. 12(1). 23–33. 8 indexed citations
4.
Rosenblad, Andreas, Janeth Leksell, Björn Eliasson, et al.. (2016). Resource allocation and organisational features in Swedish primary diabetes care: Changes from 2006 to 2013. Primary care diabetes. 11(1). 20–28. 10 indexed citations
5.
Alvarsson, Michael, G. Sundkvist, I. Lager, et al.. (2007). Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up. Diabetes Obesity and Metabolism. 10(5). 421–429. 44 indexed citations
6.
Alvarsson, Michael, G. Sundkvist, I. Lager, et al.. (2003). Beneficial Effects of Insulin Versus Sulphonylurea on Insulin Secretion and Metabolic Control in Recently Diagnosed Type 2 Diabetic Patients. Diabetes Care. 26(8). 2231–2237. 127 indexed citations
7.
Bygren, Lars Olov, et al.. (1999). Survival during and after hospitalization: a medical record linkage. International Journal of Health Care Quality Assurance. 12(1). 13–17. 3 indexed citations
8.
9.
Hardell, Lennart, Gösta Holmgren, Lars Steen, Mats Fredrikson, & Olav Axelson. (1995). Occupational and Other Risk Factors for Clinically Overt Familial Amyloid Polyneuropathy. Epidemiology. 6(6). 598–601. 10 indexed citations
10.
Suhr, Ole B., Anna Danielsson, Gösta Holmgren, & Lars Steen. (1994). Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. Journal of Internal Medicine. 235(5). 479–485. 164 indexed citations
11.
Steen, Lars, Gösta Holmgren, Ole B. Suhr, et al.. (1994). World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid. 1(2). 138–142. 42 indexed citations
12.
Johansson, Ingegerd, et al.. (1992). Salivary hypofunction in patients with familial amyloidotic polyneuropathy. Oral Surgery Oral Medicine Oral Pathology. 74(6). 742–748. 9 indexed citations
13.
Hamilton, Jean A., L. K. Steinrauf, Juris J. Liepnieks, et al.. (1992). Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1139(1-2). 9–16. 28 indexed citations
14.
15.
Suhr, Ole B., Åke Danielsson, & Lars Steen. (1992). Bile Acid Malabsorption Caused by Gastrointestinal Motility Dysfunction? An Investigation of Gastrointestinal Disturbances in Familial Amyloidosis with Polyneuropathy. Scandinavian Journal of Gastroenterology. 27(3). 201–207. 47 indexed citations
16.
Nylander, P.-O., L. Beckman, Gösta Holmgren, & Lars Steen. (1990). Association of C3 and C4 A Complement Types with Familial Amyloidotic Polyneuropathy. Human Heredity. 40(5). 272–277. 9 indexed citations
17.
Sandgren, O, Gösta Holmgren, Erik Lundgren, & Lars Steen. (1988). Restriction Fragment Length Polymorphism Analysis of Mutated Transthyretin in Vitreous Amyloidosis. Archives of Ophthalmology. 106(6). 790–792. 15 indexed citations
18.
Holmgren, Gösta, et al.. (1988). Homozygosity for the transthyretin‐met30‐gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clinical Genetics. 34(5). 333–338. 58 indexed citations
19.
Bjerle, Per, et al.. (1987). Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise. European Journal of Clinical Pharmacology. 33(1). 15–20. 3 indexed citations
20.
Nyhlin, Henry, et al.. (1982). Colonic biopsy: A new technique. British journal of surgery. 69(3). 150–150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliezer J. Holtzman Breakdown of academic impact, for papers by Zebulun D. Horowitz Breakdown of academic impact, for papers by Claude G. Biava Breakdown of academic impact, for papers by J V Leonard Breakdown of academic impact, for papers by P Lohse Breakdown of academic impact, for papers by M Odièvre Breakdown of academic impact, for papers by Kirk N. Campbell Breakdown of academic impact, for papers by Minghui Zhao Breakdown of academic impact, for papers by R.A. Hannon Breakdown of academic impact, for papers by George Hug
Rankless by CCL
2026